Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Triamterene measurement (procedure) |
Component |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene adverse reaction (disorder) |
Causative agent (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to triamterene (finding) |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-triamterzide 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-triamterzide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamterene and thiazide diuretic adverse reaction |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydrochlorothiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamterene+thiazide diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chlortalidone and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benzthiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene and loop diuretic adverse reaction |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to triamterene and loop diuretic |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to triamterene and thiazide diuretic |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Triamterene+loop diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Furosemide- and triamterene-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to triamterene (finding) |
Causative agent (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to triamterene and loop diuretic |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to triamterene and thiazide diuretic |
Causative agent (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene 50 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely triamterene 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene 50 mg oral capsule |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide- and triamterene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing benzthiazide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlortalidone and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide- and triamterene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlortalidone and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydrochlorothiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlortalidone and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydrochlorothiazide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzthiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzthiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamterene (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |